Cargando…

Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review

BACKGROUND: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging. METHODS: We retrospectively reviewed CT and PET/CT scans of 26 patients with a thymic cancer (n = 9) or thymoma (n = 17). Chest CT fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Scagliori, Elena, Evangelista, Laura, Panunzio, Annalori, Calabrese, Fiorella, Nannini, Nazarena, Polverosi, Roberta, Pomerri, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511321/
https://www.ncbi.nlm.nih.gov/pubmed/26273398
http://dx.doi.org/10.1111/1759-7714.12197
_version_ 1782382313274867712
author Scagliori, Elena
Evangelista, Laura
Panunzio, Annalori
Calabrese, Fiorella
Nannini, Nazarena
Polverosi, Roberta
Pomerri, Fabio
author_facet Scagliori, Elena
Evangelista, Laura
Panunzio, Annalori
Calabrese, Fiorella
Nannini, Nazarena
Polverosi, Roberta
Pomerri, Fabio
author_sort Scagliori, Elena
collection PubMed
description BACKGROUND: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging. METHODS: We retrospectively reviewed CT and PET/CT scans of 26 patients with a thymic cancer (n = 9) or thymoma (n = 17). Chest CT findings documented were qualitative and quantitative. Both qualitative and semiquantitative data were recovered by PET/CT. The comparisons among histological entities, outcome, and qualitative data from CT and PET/CT were made by non-parametric analysis. RESULTS: PET/CT resulted positive in 15/17 patients with thymoma. CT was available in 5/9 (56%) patients with thymic cancer and in 3/17 with thymoma. All quantitative CT parameters were significantly higher in patients with thymic cancer than thymoma (maximum axial diameter: 45 vs. 20 mm, maximum longitudinal diameter: 69 vs. 21 mm and volume: 77.91 vs. 4.52 mL; all P < 0.05). Conversely, only metabolic tumor volume (MTV) and total lesion glycolysis were significantly different in patients with thymic cancer than thymoma (126.53 vs. 6.03 cm3 and 246.05 vs. 20.32, respectively; both P < 0.05). After a median follow-up time of 17.45 months, four recurrences of disease occurred: three in patients with thymic cancer and one with a type B2 thymoma. CT volume in patients with recurrent disease was 102.19 mL versus a median value of 62.5 mL in six disease-free patients. MTV was higher in the recurrent than disease-free patient subset (143.3 vs. 81.13 cm(3)), although not statistically significant (P = 0.075). CONCLUSION: Our preliminary results demonstrated that both morphological and metabolic volume could be useful from a diagnostic and prognostic point of view in thymic cancer and thymoma patients. A large multi-center clinical trial experience for confirming the findings of this study seems mandatory.
format Online
Article
Text
id pubmed-4511321
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45113212015-08-13 Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review Scagliori, Elena Evangelista, Laura Panunzio, Annalori Calabrese, Fiorella Nannini, Nazarena Polverosi, Roberta Pomerri, Fabio Thorac Cancer Original Articles BACKGROUND: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging. METHODS: We retrospectively reviewed CT and PET/CT scans of 26 patients with a thymic cancer (n = 9) or thymoma (n = 17). Chest CT findings documented were qualitative and quantitative. Both qualitative and semiquantitative data were recovered by PET/CT. The comparisons among histological entities, outcome, and qualitative data from CT and PET/CT were made by non-parametric analysis. RESULTS: PET/CT resulted positive in 15/17 patients with thymoma. CT was available in 5/9 (56%) patients with thymic cancer and in 3/17 with thymoma. All quantitative CT parameters were significantly higher in patients with thymic cancer than thymoma (maximum axial diameter: 45 vs. 20 mm, maximum longitudinal diameter: 69 vs. 21 mm and volume: 77.91 vs. 4.52 mL; all P < 0.05). Conversely, only metabolic tumor volume (MTV) and total lesion glycolysis were significantly different in patients with thymic cancer than thymoma (126.53 vs. 6.03 cm3 and 246.05 vs. 20.32, respectively; both P < 0.05). After a median follow-up time of 17.45 months, four recurrences of disease occurred: three in patients with thymic cancer and one with a type B2 thymoma. CT volume in patients with recurrent disease was 102.19 mL versus a median value of 62.5 mL in six disease-free patients. MTV was higher in the recurrent than disease-free patient subset (143.3 vs. 81.13 cm(3)), although not statistically significant (P = 0.075). CONCLUSION: Our preliminary results demonstrated that both morphological and metabolic volume could be useful from a diagnostic and prognostic point of view in thymic cancer and thymoma patients. A large multi-center clinical trial experience for confirming the findings of this study seems mandatory. John Wiley & Sons, Ltd 2015-07 2015-07-02 /pmc/articles/PMC4511321/ /pubmed/26273398 http://dx.doi.org/10.1111/1759-7714.12197 Text en © 2014 The Authors. Thoracic Cancer published by Tianjin Lung Cancer Institute and Wiley Publishing Asia Pty Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Scagliori, Elena
Evangelista, Laura
Panunzio, Annalori
Calabrese, Fiorella
Nannini, Nazarena
Polverosi, Roberta
Pomerri, Fabio
Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
title Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
title_full Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
title_fullStr Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
title_full_unstemmed Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
title_short Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
title_sort conflicting or complementary role of computed tomography (ct) and positron emission tomography (pet)/ct in the assessment of thymic cancer and thymoma: our experience and literature review
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511321/
https://www.ncbi.nlm.nih.gov/pubmed/26273398
http://dx.doi.org/10.1111/1759-7714.12197
work_keys_str_mv AT scagliorielena conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview
AT evangelistalaura conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview
AT panunzioannalori conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview
AT calabresefiorella conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview
AT nannininazarena conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview
AT polverosiroberta conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview
AT pomerrifabio conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview